These slides are intended to educate the scientific and medical community and keep them fully informed about continuing progress, as is their right, stipulated.
Hon-chi Yip Department of Surgery North District Hospital.
Bevacizumab: Antiangiogenic therapy for breast cancer: where do we stand? Fortunato Ciardiello Division of Medical Oncology, Department of Clinical and.
Nicolae Bacalbasa “Carol Davila” University Of Medicine and Pharmacy.
BCT for multifocal multicentric breast cancer - Is it contraindicated?
Can cancer brain metastases be treated using humanized monoclonal antibodies: a pilot pharmacological study Guilhem BOUSQUET, Anne JANIN University Paris.
Start or Switch?: Latest data from ABCSG/ARNO
Adapted from American Cancer Society (2006) and Hulka et al. (2001).
PERSPECTIVAS ACTUALES Y FUTURAS EN EL MANEJO DEL CÁNCER DE MAMA PRECOZ. PARTE II
A Report from SABCS Up-to-Date Review of the Treatment of Advanced Breast Cancer
Enfermedad Triple Negativa: ¿hacia dónde vamos?
